Skip to main content
SpringerLink
Log in

Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Krenning EP, Teunissen JJ, Valkema R, de Herder WW, de Jong M, Kwekkeboom DJ (2005) Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors. J Endocrinol Invest 28(11 Suppl International):146–150

    PubMed  CAS  Google Scholar 

  2. Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, Dierckx RA, Paganelli G (2009) Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest 32(4):360–369

    PubMed  CAS  Google Scholar 

  3. Bodei L, Cremonesi M, Ferrari M, Pacifici M, Grana CM, Bartolomei M, Baio SM, Sansovini M, Paganelli G (2008) Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors. Eur J Nucl Med Mol Imaging 35(10):1847–1856

    Article  PubMed  CAS  Google Scholar 

  4. Cremonesi M, Ferrari M, Di Dia A, Botta F, De Cicco C, Bodei L, Paganelli G (2011) Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapy. Q J Nucl Med Mol Imaging 55(2):155–167

    PubMed  CAS  Google Scholar 

  5. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O’dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP (2005) Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 46(Suppl 1):62S–66S

    PubMed  CAS  Google Scholar 

  6. Merola E, Capurso G, Campana D, Panzuto F, Monarca B, Tomassetti P, Delle Fave G (2010) Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. Dig Liver Dis 42(6):457–458

    Article  PubMed  Google Scholar 

  7. Sierra ML, Agazzi A, Bodei L, Pacifici M, Aricò D, De Cicco C, Quarna J, Sansovini M, De Simone M, Paganelli G (2009) Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC. Cancer Biother Radiopharm 24(6):659–665

    Article  PubMed  CAS  Google Scholar 

  8. Flach J, Dicker F, Schnittger S, Schindela S, Kohlmann A, Haferlach T, Kern W, Haferlach C (2011) An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Leukemia 25(4):713–718

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haematology Department and Bone Marrow Transplant Unit, San Maurizio Regional Hospital, Bolzano, South Tyrol, Italy

    Andrea Piccin, Irene Pusceddu & Sergio Cortelazzo

  2. Department of Nuclear Medicine - Radiometabolic Therapy, Istituto Europeo di Oncologia, Milan, Italy

    Chiara Maria Grana & Giovanni Paganelli

  3. Pathology Department, San Maurizio Regional Hospital, Bolzano, Italy

    Giovanni Negri

Authors
  1. Andrea Piccin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Maria Grana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giovanni Negri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irene Pusceddu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Paganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sergio Cortelazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Piccin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piccin, A., Grana, C.M., Negri, G. et al. Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy. Ann Hematol 91, 299–300 (2012). https://doi.org/10.1007/s00277-011-1237-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1237-9

Keywords

Search

Navigation